MK-677 · Research brief

Does Tesamorelin Need Refrigeration After Reconstitution?

Real Peptides Research TeamEditorial

Updated September 9, 202610 min read

60 WORDS

Short answer

A reconstituted peptide vial that sat on a bench over a weekend looks exactly like one that never left the fridge. Clear, colorless, nothing floating in it. That is the whole problem, and it is why does tesamorelin need to be refrigerated after reconstitution is a question worth settling before the solvent goes in, not after a result comes back…

Key takeaways

Reconstituted tesamorelin should be held at 2-8°C and protected from light, while lyophilized tesamorelin powder is typically stored frozen at -20°C or below.
Water is the reactant that drives hydrolysis, deamidation and oxidation, which is the entire reason dry powder tolerates ambient shipping and solution does not.
Tesamorelin is a GHRH analogue carrying a trans-3-hexenoyl group on the N-terminal tyrosine, a modification that resists DPP-4 cleavage but confers no protection against chemical degradation in a vial.
Freeze-thaw damage occurs at the ice-water interface through cryoconcentration and surface adsorption, so aliquoting into single-use volumes before the first freeze matters more than the exact freezer temperature.
A degraded peptide solution usually looks completely normal, because deamidation and oxidation change mass and charge rather than clarity or color.
The certificate of analysis documents material at the point of testing only; the lot number is the link between that document and the vial in hand.

Real Peptides supplies research-grade compounds to labs that run their own analytics, and cold-chain questions reach us more often than purity questions do. Our team has watched the same pattern repeat: handling errors after reconstitution destroy more usable material than anything that happens during synthesis or shipping.

Does tesamorelin need to be refrigerated after reconstitution?

Yes. Reconstituted tesamorelin should be held at 2-8°C, shielded from light, and treated as a short-lived working solution rather than a stable stock. Lyophilized tesamorelin powder is far more robust and is typically stored frozen at -20°C or below. Aliquot before any freezing so material is never thawed twice.

The oversimplification worth correcting is that refrigeration is a single instruction covering a single product. In a lab, tesamorelin exists in two chemically different states, dry lyophilized powder and aqueous solution, and their stability profiles are not remotely comparable. What follows covers why water changes the math, the temperature ranges typical for lyophilized peptides in laboratory handling, what freeze-thaw and light exposure actually do at the molecular level, and how the lot label and certificate of analysis connect to storage decisions.

Water is the variable that changes everything, not the thermometer

Lyophilization, or freeze-drying, strips nearly all water out of the peptide, and water is the reactant driving most degradation chemistry. That single fact explains why a dry vial survives a shipping journey while a reconstituted one needs a refrigerator within hours.

Tesamorelin is a synthetic analogue of human growth hormone-releasing hormone: the 44-amino-acid GHRH sequence carrying a trans-3-hexenoyl group on the N-terminal tyrosine. That acyl modification is what confers resistance to dipeptidyl peptidase-4 (DPP-4), the enzyme that clips native GHRH near the N-terminus within minutes in plasma. Enzymatic resistance is not the same thing as chemical stability. In solution the molecule is still exposed to hydrolysis of the amide backbone, deamidation of asparagine and glutamine residues (asparagine converts to aspartate and isoaspartate, altering the molecule without altering its appearance), oxidation of methionine and tryptophan side chains, and aggregation, where partially unfolded chains associate with each other.

Every one of those pathways is temperature-dependent. As a general chemistry rule of thumb, reaction rates roughly double for each 10°C rise, which is why the gap between a 22°C bench and a 4°C refrigerator is not a small one. Cooling to 2-8°C does not stop degradation. It slows it enough that a short working window becomes realistic.

So when a researcher asks does tesamorelin have to be refrigerated, the honest split is this: dry powder tolerates brief ambient excursions in transit because there is almost no free water available to react; the reconstituted solution gets no such grace. In our experience fielding handling questions from research buyers, the labs that lose material are rarely the ones that mishandled powder. They are the ones that treated a reconstituted vial as a reagent stock with a shelf life measured in months.

Laboratory preparation tool

The easiest way to get reconstitution right: enter what's in the vial and how much bacteriostatic water you're adding, and get the exact concentration and measured volumes for your lab work.

One thing to understand before you calculate: this tool — and everything we sell — is for education and laboratory research. Researchers and labs use it to prepare and document research solutions. It isn't medical advice or dosing guidance, and nothing here is for human or veterinary consumption. Full details in our Terms of Service.

Vial contentsmgBacteriostatic water addedmLQuantity of material to measuremgOptional

Everything this calculator returns describes a solution on a lab bench: milligrams of material, milliliters of solvent, the concentration that results. That's by design — it's an educational tool for researchers, and it offers no guidance about administering anything to anyone. What you do in your lab is governed by your institution's protocols and applicable law.

Open the full peptide calculator →

Does tesamorelin need to be refrigerated after reconstitution, or is freezing the better call?

Refrigeration at 2-8°C is the default for a vial in active use. Freezing at -20°C or -80°C is the option for anything that will not be consumed inside that short window. Both are correct answers to different questions.

Typical laboratory practice for reconstituted peptides puts the working window at days to a few weeks under refrigeration, with the real figure depending on concentration, solvent, pH and how often the septum gets pierced. Concentrated solutions generally hold up better than very dilute ones, partly because of adsorption: peptide molecules bind to glass and plastic surfaces, and at low concentrations that surface loss can remove a meaningful fraction of the material without any chemical degradation at all. Low-binding and siliconized vials exist for exactly this reason.

Here is the part most storage guides skip entirely. Freeze-thaw damage is not really about cold. It happens at the ice-water interface. As ice crystals form, peptide molecules concentrate in the shrinking liquid phase and adsorb onto the growing crystal surface, which is enough to unfold and aggregate them, and cryoconcentration simultaneously shifts local pH as buffer components crystallize at different rates. Each additional cycle compounds the damage. Aliquoting into single-use volumes before the first freeze matters far more than the exact freezer setpoint.

Light is the third variable and the most neglected one. Tryptophan, tyrosine and methionine residues photo-oxidize under UV and under prolonged fluorescent exposure, so amber vials or foil wrapping is standard practice for solutions held more than a day.

Solvent chemistry matters too. Bacteriostatic water contains roughly 0.9% benzyl alcohol as a preservative, which suppresses microbial growth in a multi-draw vial, while sterile water offers no such protection. That is a formulation consideration for bench work, not a use instruction.

What the vial label, the appearance and the COA can and cannot tell you

A clear, colorless solution is a necessary sign, not a sufficient one. Cloudiness, a yellow tint, stringy material or visible particulates point to aggregation, precipitation or microbial contamination, and material in that condition is not analytically trustworthy. The reverse does not hold. A solution can lose a substantial share of its intact peptide content to deamidation or oxidation and look completely unchanged, because those modifications shift mass by a few daltons and shift charge distribution, not clarity.

That is why the lot number on the vial matters. Every lot identifier ties back to the certificate of analysis for that specific synthesis batch, which reports identity by mass spectrometry and purity by reverse-phase HPLC alongside net peptide content. The COA describes material as it left analytical testing. It says nothing about what happened in a given freezer afterwards. Storage discipline is the only bridge between those two points, which is why labs running longer studies re-verify by HPLC rather than assume.

Researchers can match a lot number against batch documentation through our certificate of analysis records, and the same small-batch synthesis and per-lot testing approach runs across the Real Peptides catalog, including related growth hormone secretagogue research compounds such as GHRP-2 and MK-677, each with its own handling profile.

One compliance point, stated plainly: research-grade tesamorelin is supplied for laboratory research only, is not an FDA-approved drug product, and is not for human or veterinary use. Anyone with questions about growth hormone axis medicine for themselves or for an animal should speak with a licensed physician or veterinarian rather than extrapolating from research handling documentation.

Storage states compared: temperature, window and dominant risk

The table below sets the four handling states side by side, because the correct temperature depends entirely on which state the material is in. Ranges are typical for lyophilized peptides handled in a laboratory setting, not manufacturer specifications for any finished drug product.

Storage state	Typical temperature range	Practical working window	Dominant degradation risk	Bottom line
Lyophilized powder, long-term	-20°C, or -80°C for extended archival	Months to years in a sealed, dry, intact vial	Moisture ingress through a compromised seal, or condensation when a cold vial is opened in humid air	The most stable state available; keep it dry and sealed and temperature does most of the work for you
Lyophilized powder, in transit	Ambient for short shipping periods	Days	Cumulative heat exposure across repeated or extended excursions	Brief ambient transit is normal for dry peptide; log arrival condition and return the vial to the freezer promptly
Reconstituted, refrigerated	2-8°C, protected from light	Short, measured in days to a few weeks depending on concentration and solvent	Hydrolysis, deamidation, oxidation, plus microbial growth in preservative-free solvent	The standard answer for a vial in active use; treat it as perishable rather than as stock
Reconstituted, frozen aliquots	-20°C to -80°C in single-use volumes	Longer than refrigeration but still finite	Aggregation at the ice-water interface during each freeze and thaw	Worth doing only if the solution is aliquoted before the first freeze, never after
Reconstituted, room temperature	20-25°C	Hours	Every degradation pathway running at its fastest rate, plus contamination risk	Acceptable only for the duration of an active bench procedure, never for storage

What If: Tesamorelin Handling Scenarios

What if a reconstituted vial was left at room temperature overnight?

Treat the material as compromised for quantitative work and verify by HPLC before relying on it. At roughly 20-25°C, hydrolysis, deamidation and oxidation all proceed several times faster than at 4°C, and a preservative-free solvent adds microbial risk on top of the chemistry. There is no visual test that resolves this. A single overnight excursion may leave enough intact peptide for qualitative work and still invalidate a concentration-dependent assay.

What if the lyophilized vial arrived warm after a shipping delay?

Record the arrival condition, return the vial to freezer storage, and check the lot documentation before use. Dry lyophilized peptide is comparatively tolerant of short ambient excursions precisely because there is minimal free water available for hydrolysis, which is why cold packs on peptide shipments are a buffer rather than a strict requirement. Repeated or prolonged heat exposure is the real concern, not a single warm transit leg.

What if the solution looks fine but assay results have started drifting?

Run a purity check by reverse-phase HPLC against the original certificate of analysis rather than adjusting the experiment. Drifting potency in a clear solution is the classic signature of gradual deamidation, oxidation or surface adsorption, none of which produce visible change. Dilute solutions in untreated glass are especially prone to adsorptive loss, so concentration and vial type belong in the troubleshooting list alongside temperature.

What if a vial has been thawed and refrozen more than once?

Assume cumulative aggregation and stop using that vial for quantitative endpoints. Each cycle drives peptide molecules onto growing ice crystal surfaces and shifts local pH as buffer components crystallize out of solution, and the damage stacks rather than resets. This is the strongest argument for aliquoting immediately after reconstitution: five single-use aliquots survive far better than one vial opened five times.

What if the appearance of the powder differs from the previous lot?

Compare the lot number against its certificate of analysis before reconstituting anything. Lyophilized peptide cake appearance varies legitimately between batches with fill volume, freezing rate and residual moisture, so a flatter or more fragmented cake is not automatically a quality signal. Discoloration, stickiness or a collapsed, glassy cake is different, and warrants analytical confirmation rather than assumption.

The unglamorous truth about peptide storage failures

Let's be direct about this: the overwhelming majority of ruined research peptide is not ruined by bad synthesis or bad shipping. It is ruined quietly, in a refrigerator, by a vial that was reconstituted three months ago and never aliquoted. Purity certificates and cold packs get all the attention because they are the parts a supplier controls and a buyer can inspect. The refrigerator is the part nobody photographs. A 99% pure peptide handled carelessly after reconstitution ends up performing worse than a 95% peptide that was aliquoted, frozen once and shielded from light.

Ask does tesamorelin need to be refrigerated after reconstitution and you get a one-word answer, but that one word hides the part that actually determines whether a study is salvageable. The refrigerator buys time, it does not buy stability, and nothing about a clear solution tells you how much of that time is left. The labs that get consistent data are not the ones with better freezers. They are the ones that decided, at the moment of reconstitution, exactly how the material would be split, labeled and consumed, and then never improvised after that.

References

Peer-reviewed sources on Tesamorelin indexed in PubMed, listed for research context. Real Peptides supplies Tesamorelin for laboratory research use only.

Body composition, hepatic fat, metabolic, and safety outcomes of Tesamorelin, a GHRH analogue, in HIV-associated lipodystrophy: A meta-analysis of randomized controlled trials. Obesity research & clinical practice, 2026. PMID 41545261. doi:10.1016/j.orcp.2026.01.002
Tesamorelin: a review of its use in the management of HIV-associated lipodystrophy. Drugs, 2011. PMID 21668043. doi:10.2165/11202240-000000000-00000
Effects of Tesamorelin on Neurocognitive Impairment in Persons With HIV and Abdominal Obesity. The Journal of infectious diseases, 2025. PMID 39813152. doi:10.1093/infdis/jiaf012
Efficacy and safety of tesamorelin in people with HIV on integrase inhibitors. AIDS (London, England), 2024. PMID 38905488. doi:10.1097/QAD.0000000000003965
Effect of tesamorelin in people with HIV with and without dorsocervical fat: Post hoc analysis of phase III double-blind placebo-controlled trial. Journal of clinical and translational science, 2023. PMID 36845310. doi:10.1017/cts.2022.515
Tesamorelin improves fat quality independent of changes in fat quantity. AIDS (London, England), 2021. PMID 33756511. doi:10.1097/QAD.0000000000002897
Delineating tesamorelin response pathways in HIV-associated NAFLD using a targeted proteomic and transcriptomic approach. Scientific reports, 2021. PMID 34006921. doi:10.1038/s41598-021-89966-y
Effects of tesamorelin on hepatic transcriptomic signatures in HIV-associated NAFLD. JCI insight, 2020. PMID 32701508. doi:10.1172/jci.insight.140134

Build a pack

Researching more than one compound?

Build a multi-vial pack and the discount applies automatically as you add doses.

Start a pack

Questions

Yes. Once reconstituted, tesamorelin should be held at 2-8°C and protected from light, with a working window typically measured in days to a few weeks rather than months. Refrigeration slows hydrolysis, deamidation and oxidation but does not stop them, so solution in active use should be treated as perishable material.

In lyophilized powder form, tesamorelin is normally kept frozen at -20°C or below rather than merely refrigerated, and it tolerates short ambient excursions during shipping because there is almost no free water available to react. Once reconstituted, refrigeration at 2-8°C becomes the minimum standard for laboratory handling.

Typical laboratory practice for reconstituted peptides gives a window of days to a few weeks at 2-8°C, but the real figure depends on concentration, solvent, pH and how many times the vial is pierced. Dilute solutions degrade faster and also lose material through adsorption to glass and plastic surfaces. Labs running extended studies re-verify purity by HPLC rather than relying on a calendar.

Frozen storage at -20°C or -80°C extends usable life beyond refrigeration, but only if the solution is split into single-use aliquots before the first freeze. Freeze-thaw damage occurs at the ice-water interface, where peptide molecules concentrate and adsorb onto growing ice crystals, and the damage accumulates with every additional cycle.

Dry lyophilized peptide is comparatively tolerant of short ambient transit because water, the reactant behind most degradation chemistry, has been removed. Record the arrival condition and move the vial to freezer storage promptly. Cumulative or prolonged heat exposure across multiple excursions is the meaningful risk, not one warm delivery.

Cloudiness, stringy material, a yellow tint or visible particulates indicate aggregation, precipitation or microbial contamination, and that material is no longer analytically reliable. The absence of those signs proves very little though. Deamidation and oxidation change the molecule's mass and charge by small amounts while leaving the solution perfectly clear.

Bacteriostatic water contains roughly 0.9% benzyl alcohol as a preservative, which suppresses microbial growth in a vial that will be accessed multiple times, while sterile water provides no antimicrobial protection at all. Solvent selection is a laboratory formulation decision that should follow the protocol and the analytical method in use.

Yes. Tryptophan, tyrosine and methionine residues photo-oxidize under UV light and under prolonged fluorescent room lighting, which is why amber vials or foil wrapping is standard for solutions held longer than a day. Light damage is invisible in a clear solution and shows up only in analytical testing.

The principles are consistent across lyophilized peptides: dry powder frozen, solution refrigerated and protected from light, aliquoted before freezing. The differences sit in sequence-specific vulnerabilities, since peptides carrying methionine, tryptophan or asparagine residues face different oxidation and deamidation risks. Handling documentation should be checked per compound rather than generalized.

Each vial carries a lot number that maps to the certificate of analysis for that synthesis batch, which reports identity by mass spectrometry, purity by reverse-phase HPLC and net peptide content. Real Peptides publishes batch documentation that researchers can match against the lot identifier on the label before starting work.

No. Research-grade tesamorelin is supplied for laboratory research only and is not an FDA-approved drug product, so it carries no approved labeling, no prescribing information and no human or veterinary use indication. Approved drug products undergo formulation-specific review and batch controls that research-use compounds do not.

RESEARCH USE ONLY · NOT EVALUATED BY THE FDA